Ipca Lab Q4 net profit up 84% at Rs 137 cr

Drug firm Ipca Laboratories today posted 84.10% jump in net profit at Rs 137.03 crore for the fourth quarter ended March 31, 2013-14.

The company had reported net profit of Rs 74.43 crore during the January-March same period of the 2012-13 fiscal.

Net sales of the company during Q4, 2013-14 were Rs 739.81 crore, up 12.32% from Rs 658.64 crore in the year-ago period, Ipca Laboratories said in a filing to the BSE.

The company's Q4 revenue from domestic formulations business stood at Rs 196.56 crore, up 10%, while the revenue from exports stood at Rs 373.18 crore, up 19%.

The Ipca Labs scrip was trading at Rs 785 on the BSE in the afternoon trade, down 0.39% from the previous close.

EDITORIAL OF THE DAY

  • PSU banks can take a lesson from their private peers on disclosures

    The country’s top private lenders ICICI Bank and Axis Bank declared their fourth quarter earnings recently and both stepped up their asset quality d

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Tushar Gandhi

An unexplored side of rural enterprise

What is rural enterprise? Ask this qu­estion and 9 out ...

Rajgopal Nidamboor

Timeless idiom of mindful living

Each of us, according to scholar-historian Felipe Fernandez-Armesto, is familiar ...

Dharmendra Khandal

So, how do we define a 'vermin'?

These days there’s an ongoing debate whether to declare various ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture